Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.047.784 |
Chemical and physical data | |
Formula | C41H67NO15 |
Molar mass | 813.979 g·mol |
3D model (JSmol) | |
Melting point | 155 to 156 °C (311 to 313 °F) |
Solubility in water | Soluble in acidic/low pH water; Very soluble in methanol, chloroform, ethyl acetate, benzene, ethyl ether; Almost completely in ethanol(>95.5) mg/mL (20 °C) |
SMILES
| |
InChI
| |
(verify) |
Midecamycin is a macrolide antibiotic that is synthesized from Streptomyces mycarofaciens.
Physical Properties
Its melting point may vary depending on the compound type and the source consulted. For example, the Merck Index gives a melting point of 155-156 Celsius for the A1 type while the Japanese Pharmacopoeia reports 153-158 Celsius. The Merck Index also gives a melting point of 122-125 Celsius for the A3 type.
References
- Salhi A, Vindel JA, Brunaud M, Berceaux G, Marin A, Wuatelet C (1977). "Properties of midecamycin, a new macrolide antibiotic". Giornale Italiano di Chemioterapia. 24 (1–2): 67–76. PMID 308022.
- Wang YG, Hutchinson CR (1989). "Cloning of midecamycin biosynthetic genes from Streptomyces mycarofaciens 1748". Chinese Journal of Biotechnology. 5 (4): 191–201. PMID 2491329.
This systemic antibiotic-related article is a stub. You can help Misplaced Pages by expanding it. |
Antibacterials that inhibit protein synthesis (J01A, J01B, J01F, J01G, QJ01XQ) | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
30S |
| ||||||||||||||
50S | |||||||||||||||
|